Why India’s Deeptech Ambitions Face a Capital and Customer Gap Despite Policy Push

• admin
• April 2, 2026
• Uncategorized
• 0 Comments

India’s deeptech ecosystem requires substantial patient capital and anchor customers to scale beyond prototype stages, according to Indian American technology executives. The structural challenge lies not in innovation capacity but in bridging the commercialisation gap that separates laboratory breakthroughs from market-ready products.

New Delhi, April 2025 — Indian American chief executives have identified two critical bottlenecks constraining India’s deeptech aspirations: insufficient long-term capital deployment and the absence of large domestic anchor clients willing to adopt nascent technologies. Their assessment, delivered at a recent industry dialogue, underscores a persistent weakness in India’s innovation infrastructure that government initiatives have yet to adequately address.

What Is Holding Back India’s Deeptech Sector?

India’s deeptech ventures — spanning semiconductors, quantum computing, advanced materials, and synthetic biology — face a funding structure misaligned with their development timelines. Venture capital in India remains predominantly oriented toward consumer internet and fintech plays offering quicker exits, typically within five to seven years. Deeptech ventures routinely require decade-long gestation periods before achieving commercial viability. The Indian American executives noted that Silicon Valley’s deeptech success rests on specialised funds willing to accept extended holding periods, a category largely absent in Indian markets.

Why Do Anchor Customers Matter for Deeptech Scale?

The customer acquisition challenge proves equally structural. Indian deeptech startups struggle to secure pilot programmes with large domestic corporations and government entities. Public sector undertakings and established conglomerates remain risk-averse when evaluating unproven indigenous technologies, often preferring imported solutions with established track records. The United States addressed this dynamic through defence procurement and federal research contracts that effectively de-risked early-stage deeptech ventures. India’s defence and space agencies have begun similar engagements, but scale remains limited relative to ecosystem requirements.

How Does India’s Deeptech Funding Compare Globally?

India’s deeptech investment gap becomes stark when measured against competing innovation economies.

• India attracted approximately $900 million in deeptech funding in 2024, compared to $12 billion deployed in China’s deeptech sector during the same period
• The average Series A round for Indian deeptech startups stands at $4-6 million, roughly one-third the equivalent in the United States
• Government programmes like the India Semiconductor Mission have allocated ₹76,000 crore, but disbursement velocity remains slow
• Fewer than 15 dedicated deeptech-focused venture funds currently operate in India, versus over 200 in the United States
• Corporate venture arms of Indian conglomerates have committed less than 5% of their portfolios to deeptech bets

What Policy Shifts Could Address These Gaps?

The Indian American executives suggested several interventions beyond existing schemes. Production-linked incentives, while valuable for manufacturing scale, do not address early-stage research commercialisation. A sovereign deeptech fund with mandated 15-year horizons could bridge the patient capital deficit. Mandatory technology procurement quotas for public sector entities would create guaranteed first customers for qualifying Indian deeptech products. Tax incentives for corporations investing in pre-revenue deeptech ventures could unlock private capital currently sitting on the sidelines.

Analyst’s View

India’s deeptech trajectory will likely bifurcate over the next three years. Sectors with clear government procurement pathways — defence electronics, space components, certain semiconductor categories — will attract sufficient capital and customers to achieve scale. Ventures in synthetic biology, advanced materials, and quantum applications face prolonged funding droughts absent structural policy intervention. Investors should monitor the disbursement rate of announced government programmes rather than headline allocation figures. The true test arrives when Indian conglomerates begin acquiring domestic deeptech startups at meaningful valuations rather than licensing foreign alternatives.